1. Home
  2. Analysis
  3. Banzel
  4. Memory-loss

Banzel and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is reported as a side effect among people who take Banzel (rufinamide), especially for people who are female, 20-29 old, also take Ativan, and have Seizures.

The phase IV clinical study analyzes which people have Memory loss when taking Banzel. It is created by eHealthMe based on reports of 1,559 people who have side effects when taking Banzel from the FDA, and is updated regularly.

What is Banzel?

Banzel has active ingredients of rufinamide. It is often used in epilepsy. eHealthMe is studying from 1,590 Banzel users. Check the latest studies of Banzel.

What is Memory loss?

Memory loss is found to be associated with 2,729 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.

On Jul, 13, 2026

1,559 people reported to have side effects when taking Banzel.
Among them, 29 people (1.86%) have Memory loss.

Could Banzel cause Memory loss?

Among these 29 people:

What is the gender of people who have Memory loss when taking Banzel? *

  • female: 74.07 %
  • male: 25.93 %

What is the age of people who have Memory loss when taking Banzel? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 12.5 %
  • 20-29: 87.5 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Banzel? *

  1. Ativan: 21 people, 72.41%
  2. Keppra: 8 people, 27.59%
  3. Depakote: 7 people, 24.14%
  4. Lamictal: 6 people, 20.69%
  5. Vimpat: 5 people, 17.24%
  6. Tegretol: 5 people, 17.24%
  7. Topamax: 4 people, 13.79%
  8. Dilantin: 4 people, 13.79%
  9. Klonopin: 2 people, 6.90%
  10. Botox: 2 people, 6.90%

What are other side effects people have besides Memory loss? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 24 people, 82.76%
  2. Fall: 20 people, 68.97%
  3. Movement - Uncoordinated: 19 people, 65.52%
  4. Atonic Seizures (minor type of seizure): 19 people, 65.52%
  5. Multiple-Drug Resistance: 19 people, 65.52%
  6. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 19 people, 65.52%
  7. Aggression: 6 people, 20.69%
  8. Suicidal Ideation: 4 people, 13.79%
  9. Nausea (feeling of having an urge to vomit): 3 people, 10.34%
  10. Nausea And Vomiting: 3 people, 10.34%

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 13.79%
  2. Affective Disorder (mental disorder): 3 people, 10.34%
  3. Psychotic Disorder: 2 people, 6.90%
  4. Headache (pain in head): 2 people, 6.90%
  5. Ammonia Increased: 2 people, 6.90%
  6. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 3.45%
  7. Dyspnea (difficult or laboured breathing): 1 person, 3.45%
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 3.45%
  9. Complex Partial Seizures (epileptic seizure): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Banzel and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Banzel:

Memory loss treatments and more:

How severe was Memory loss and when was it recovered:

Expand to all the drugs that have ingredients of rufinamide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Banzel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Memory loss:

Browse all the conditions that are associated with Memory loss:

How the study uses the data?

The study uses data from the FDA. It is based on rufinamide (the active ingredients of Banzel) and Banzel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.